Invesco
CANO

Invesco’s Cano Health, Inc. CANO Stock Holding History

Invesco’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,976
Closed -$75.5K – 3949
2023
Q3 		$75.5K Buy
2,976
+19
+0.6% +$1.56K ﹤0.01% 3760
2023
Q2 		$411K Sell
2,957
-157
-5% -$20.1K ﹤0.01% 3351
2023
Q1 		$283K Buy
3,114
+2,416
+346% +$328K ﹤0.01% 3515
2022
Q4 		$95.7K Sell
698
-60
-8% -$20.3K ﹤0.01% 3834
2022
Q3 		$657K Buy
758
+86
+13% +$53.9K ﹤0.01% 3103
2022
Q2 		$295K Buy
672
+544
+425% +$284K ﹤0.01% 3589
2022
Q1 		$81K Sell
128
-22
-15% -$13.9K ﹤0.01% 3885
2021
Q4 		$133K Buy
+150
New +$158K ﹤0.01% 3861

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco's CANO Position: Q4 2023 in Review

Invesco sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 2,976 shares — an estimated $75.5K sold.

Invesco first reported a position in CANO in Q4 2021 and held it in 8 quarters. The position peaked at $657K in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Invesco reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Invesco sold 2,976 Cano Health, Inc. shares in Q4 2023, an estimated $75.5K.
  • Invesco first reported a position in Cano Health, Inc. in Q4 2021 and held it in 8 quarters.
  • Invesco's Cano Health, Inc. position peaked at $657K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.